Hemolytic dynamics of weekly primaquine antirelapse therapy among Cambodians with acute Plasmodium vivax malaria with or without glucose-6-phosphate dehydrogenase deficiency

<br><strong>Background: </strong>Hemoglobin (Hb) data are limited in Southeast Asian glucose-6-phosphate dehydrogenase (G6PD) deficient (G6PD−) patients treated weekly with the World Health Organization–recommended primaquine regimen (ie, 0.75 mg/kg/week for 8 weeks [PQ 0.75]).<...

Full description

Bibliographic Details
Main Authors:	Taylor, W, Kheng, S, Muth, S, Tor, P, Kim, S, Bjorge, S, Topps, N, Kosal, K, Sothea, K, Souy, P, Char, C, Vanna, C, Ly, P, Khieu, V, Christophel, E, Kerleguer, A, Pantaleo, A, Mukaka, M, Menard, D, Baird, J
Format:	Journal article
Language:	English
Published:	Oxford University Press 2019

Hemolytic dynamics of weekly primaquine antirelapse therapy among Cambodians with acute Plasmodium vivax malaria with or without glucose-6-phosphate dehydrogenase deficiency

Similar Items